Tuesday, February 07, 2017 11:18:21 PM
http://www.marketwatch.com/story/bioelectronics-president-interviewed-by-the-stockradiocom-discusses-bioelectronics-the-science-of-the-chronic-pain-market-and-drug-use-2016-10-27
Andrew Whelan interview in October is compelling given that he predicts that he is close with FDA approval and at the sametime working on retail marketing partner that has the capacity to get into the 200 markets in the world that has management and financial resources in rapid and orderly mannner. Then focus on broad platform for applications for other products. The journey continues with FDA approval and look forward to the next step with a partner announcement!
http://westbrookradio.com/2016/10/26/andrew-whelan-ceo-bioelectronics-corp-biel/
Investor 100
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM